The board of directors at Arch Therapeutics have a long history of experience and education in the field of biochemistry. The chairman of the board previously worked as a professor of biochemistry at Kent State University and a postdoctoral research associate at the University of Minnesota. Other members of the board have studied biochemistry at esteemed universities such as The University of Sheffield. This wealth of knowledge and experience gives Arch Therapeutics a strong foundation on which to continue developing new and innovative treatments for various medical conditions.
Avtar Dhillon
Business Advisor
Daniel Kapp
Clinical Advisor, Wound Care &...
Elaine Whitmore
Regulatory Consultant, Advisor
James Sulat
Director
John Richards
Business Advisor
Larry Hicks
Business Advisor
Punit Dhillon
Director
Roger Gregory
Scientific Advisor
Rutledge Ellis-Behnk...
Scientific Advisor & Co-Founde...
Shri Parikh
Advisor
Steve Schwaitzberg
Clinical Advisor
Steven A. Kates
Scientific Advisor
William G. Austen
Clinical Advisor, Wound Care &...
William T. Denman
Clinical Advisor
View all